Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells
- PMID: 1769691
- PMCID: PMC1384634
Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells
Abstract
In vitro treatment of peritoneal cells with dodecylglycerol (DDG) in 10% foetal calf serum (FCS) supplemented medium RPMI-1640 results in a greatly enhanced Fc receptor-mediated phagocytic activity of macrophages. This macrophage activation process requires a serum factor in the alpha 2-globulin fraction. When mouse peritoneal cells were treated with 50 ng DDG/ml in a serum-free 0.1% egg albumin-supplemented medium RPMI-1640 (EA medium) for 30 min and cultured in EA medium containing electrophoretically fractionated alpha 2-globulin for 3 hr, a markedly enhanced activation of macrophages was observed. To improve fractionation of alpha 2-globulin, FCS was first precipitated with 50% saturated ammonium sulphate and then the supernatant electrophoretically fractionated. The resultant alpha 2-globulin fraction was unable to support activation of macrophages. Vitamin D3 binding protein (DBP) of the alpha 2-globulin fraction is known to be precipitable by 50% saturated ammonium sulphate. When human alpha 2-globulin was treated with antiserum against human DBP and used in a medium for cultivation of DDG-treated peritoneal cells, no significant activation of macrophages was observed. Cultivation of DDG-treated peritoneal cells in a medium containing a low concentration of purified human DBP (group specific component, Gc) produced a greatly enhanced ingestion activity of macrophages. Purified human Gc protein, when used in an EA medium for step-wise cultivation of DDG-treated B and untreated T cells, was efficiently converted to a macrophage-activating factor.
Similar articles
-
Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.J Immunol. 1991 Jul 1;147(1):273-80. J Immunol. 1991. PMID: 2051023
-
Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues.Cancer Res. 1988 Nov 1;48(21):6044-9. Cancer Res. 1988. PMID: 3167855
-
Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells.J Immunol. 1993 Sep 1;151(5):2794-802. J Immunol. 1993. PMID: 8360493
-
A serum factor for macrophage activation after in vitro dodecylglycerol treatment of mouse lymphocytes.Immunol Cell Biol. 1990 Apr;68 ( Pt 2):137-42. doi: 10.1038/icb.1990.19. Immunol Cell Biol. 1990. PMID: 1696561
-
Therapeutic potential of vitamin D-binding protein.Trends Biotechnol. 2004 Jul;22(7):340-5. doi: 10.1016/j.tibtech.2004.05.001. Trends Biotechnol. 2004. PMID: 15245906 Review.
Cited by
-
Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.Glycoconj J. 2016 Apr;33(2):209-18. doi: 10.1007/s10719-016-9658-2. Epub 2016 Mar 31. Glycoconj J. 2016. PMID: 27034286
-
Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.Transl Oncol. 2008 Jul;1(2):65-72. doi: 10.1593/tlo.08106. Transl Oncol. 2008. PMID: 18633461 Free PMC article.
-
Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.Oncol Lett. 2011 Jul;2(4):685-691. doi: 10.3892/ol.2011.306. Epub 2011 May 13. Oncol Lett. 2011. PMID: 22848250 Free PMC article.
-
Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.Cancer Immunol Immunother. 2008 Jul;57(7):1007-16. doi: 10.1007/s00262-007-0431-z. Cancer Immunol Immunother. 2008. Retraction in: Cancer Immunol Immunother. 2014 Dec;63(12):1349. doi: 10.1007/s00262-014-1616-x. PMID: 18058096 Free PMC article. Retracted.
-
Participation of serum proteins in the inflammation-primed activation of macrophages.Inflammation. 1994 Jun;18(3):311-22. doi: 10.1007/BF01534272. Inflammation. 1994. PMID: 8088927
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous